New Data Add To Understanding Of Repatha Evolocumab In Multiple Patient...
THOUSAND OAKS Calif. Aug. 22 2016 PRNewswire Amgen NASDAQAMGN today announced that it will present 11 abstracts at the upcoming European Society of Cardiology ESC Congress 2016 being held Aug. 2731 in...
View ArticleSentient Interactive Chosen by Medical Marketing & Media as a Top 100 Agency...
Sentient Interactive LLC a digital resultsdriven marketing agency was honored to be among the Top 100 Agencies of 2016 as chosen by Medical Marketing & Media MM&M magazine.Morristown...
View ArticleDiseaseguided approach ups specificity of statin treatment
HealthDayA diseaseguided approach to statin eligibility can improve treatment specificity according to a study published in the Aug. 30 issue of the Journal of the American College of Cardiology.
View ArticleStatin Therapy and Mortality in Older Adults With CAD
The results of this study call into question the benefit of statin therapy for secondary prevention in adults aged 80 and older. Journal of the American Geriatrics Society
View ArticleHIJPROPER trial Intensive cholesterollowering treatment No significantly...
European Society of Cardiology Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a secondline cholesterollowering medication on top of a standard...
View ArticleRegeneron and Sanofi Present Positive Phase 3 Investigational Data for...
TARRYTOWN N.Y. and PARIS Aug. 29 2016 PRNewswire &160;Regeneron Pharmaceuticals Inc. NASDAQ REGN and Sanofi today announced detailed positive results from ODYSSEY ESCAPE a Phase 3 trial which...
View ArticleNew Repatha evolocumab Analyses Show Efficacy And Safety Across Risk Groups...
THOUSAND OAKS Calif. Aug. 28 2016 PRNewswire Amgen NASDAQAMGN today announced data presented at the European Society of Cardiology ESC Congress 2016 showing Repatha&174; evolocumab consistently...
View ArticleHIJPROPER trial Intensive cholesterollowering regimen in ACS patients shows...
Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a secondline cholesterollowering medication on top of a standard statin compared to statin...
View ArticleIntensive cholesterollowering treatment No significantly better outcomes
Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a secondline cholesterollowering medication on top of a standard statin compared to statin...
View ArticleStatinRelated Muscle Symptoms More Common in Patients With Metabolic Syndrome
Connection Between Metabolic Syndrome and StatinRelated Muscle Symptoms Poses a Challenge to Clinicians JACKSONVILLE FLMarketwired August 29 2016 A new study showsRead more...
View ArticleCatalysts Coming for Esperion Therapeutics
About bempedoic acid ETC1002Bempedoic acid is a firstinclass ACLinhibitor ACLi that inhibits cholesterol biosynthesis. Bempedoic acid works like a statin to upregulate the Low Density...
View ArticleBoth statins and a Mediterraneanstyle diet can help ward off heart disease...
If you've ever have the misfortune of a heart attack or are considered at risk of heart disease or stroke your doctor will probably prescribe a statin drug such as atorvastatin Lipitor to lower your...
View ArticleStatin Underdosing Common in HigherRisk Patients Registry
The findings lend credence to the 2013 ACCAHA guidelines' emphasis on starting with highintensity statins in the highestrisk group who have the most to gain from LDL lowering the author says. Heartwire...
View ArticleMajor review to help doctors patients and public make informed decisions...
A major review of the available evidence on the safety and efficacy of statin therapy published in The Lancet intends to help doctors patients and the public make informed decisions about the use of...
View ArticleRiskbenefit profile of statin therapy 'may be more positive than expected'
A new study has indicated that the benefits of statin therapy may have been underestimated with the harms exaggerated a discovery with potential implications for inflammatory arthritis patients.Carried...
View ArticleReview Interpretation of the evidence for the efficacy and safety of statin...
This Review is intended to help clinicians patients and the public make informed decisions about statin therapy for the prevention of heart attacks and strokes. It explains how the evidence that is...
View ArticleMedical News Today Statins 'Harms have been overestimated' says review
An indepth review into the health outcomes of statin therapy suggests the benefits of the cholesterollowering drugs outweigh the risks.
View ArticleHealth Highlights Sept. 9 2016
Here are some of the latest health and medical news developments compiled by the editors of HealthDayBenefits of Statins Underestimated ReviewThe benefits of widelyused cholesterollowering statin drugs...
View ArticleCardioBrief Statin Trialists Try to Bury Debate With Evidence
MedPage Today But some disagree with review's claims of overwhelming evidence
View ArticleStatin harms exaggerated finds major review
A comprehensive review of the efficacy and safety of statins based on 30 years' research and published in The Lancet has concluded that the therapy's benefits have been underestimated and harms...
View Article